Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026)
Gyre Therapeutics (GYRE) Property, Plant & Equipment (Net) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.05% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 11.65% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 411.50% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 16.78% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -56.31% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.66% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 19.96% |
| 10 | Gyre Therapeutics | 708.31 Mn | 685.47 Mn | 26.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,767.25% |
| Dec 31, 2025 | 10.04% |
| Sep 30, 2025 | 475.28% |
| Jun 30, 2025 | 422.55% |
| Mar 31, 2025 | 201.63% |
| Dec 31, 2024 | 190.91% |
| Sep 30, 2024 | 181.91% |
| Jun 30, 2024 | 225.88% |
| Mar 31, 2024 | 295.12% |
| Dec 31, 2023 | 277.47% |
| Mar 31, 2023 | -84.99% |
| Dec 31, 2022 | 287.65% |
| Sep 30, 2022 | -28.48% |
| Jun 30, 2022 | -23.82% |
| Mar 31, 2022 | 34.02% |
| Dec 31, 2021 | 35.95% |
| Sep 30, 2021 | 62.34% |
| Jun 30, 2021 | 32.96% |
| Mar 31, 2021 | 5.53% |
| Dec 31, 2020 | 16.20% |